Is Institut National de la Sante et de la Recherche Medicale (INSERM)'s patent grant rate increasing or decreasing?

Institut National de la Sante et de la Recherche Medicale (INSERM)'s recent grant velocity is +9% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Institut National de la Sante et de la Recherche Medicale (INSERM)'s patents?

Institut National de la Sante et de la Recherche Medicale (INSERM)'s patents average 13.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Institut National de la Sante et de la Recherche Medicale (INSERM)

Q: Where does Institut National de la Sante et de la Recherche Medicale (INSERM) rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Institut National de la Sante et de la Recherche Medicale (INSERM) ranks #738 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Q: How is the Institut National de la Sante et de la Recherche Medicale (INSERM) patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 617 granted patents across 89 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Institut ranks #738 of 49,997 tracked US assignees by granted-patent volume, with 617 patents across 89 technology areas.

#738
of 49,997 US assignees by volume: Top 3%
by Innovation Score (61.8/100): 13.6
avg claims per patent: +9%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R738 · Foreign Corporation #738 · 617 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-MID 617 grants
TOP-DECILE #738/49,997
PHOTO-FINISH InvenSense
CPC-WIDE A61K · 89 areas
INNOV-STRONG 61.8/100
CLAIMS-RICH 13.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +9% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: InvenSense, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Institut’s 61.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 22.2 pts (36%) Velocity 6.5 pts (11%) Breadth 25.0 pts (40%) Claim depth 8.2 pts (13%)

Qualcomm Incorporated · highest

85
Colgate-Palmolive · near

62
Institut National… · this assignee

62
Sony Mobile… · near

62
Allison Transmission · near

62
Panduit · near

62
3D Lighting… · lowest

7

What this shows Institut's Innovation Score is 61.8/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Institut?

Each dot is one of Institut’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Institut’s own 13.6 claims/patent is at or below the 14.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Institut vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Institut's grant cadence moved

Between 2020–2024, Institut National de la Sante et de la Recherche Medicale (INSERM) received 300 grants versus 274 in 2015–2019 (+9% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2020 at 77 grants and bottomed in 2024 at 43. Lead class A61K accounts for 58.5% of the portfolio across 89 subclasses. Volume neighbours: Baxter International Inc. (#734) and Uchicago Argonne, LLC (#742).

Institut's three-year grant acceleration

From 2019–2021 to 2022–2024, Institut National de la Sante et de la Recherche Medicale (INSERM) moved from 179 to 174 grants (0.97x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,262. See the growth leaderboard.

Baxter Internatio…

620
Siemens Energy Gl…

620
Hitachi Kokusai E…

618
Semes

618
Invensense

617
Institut National… ◀

617
Bell Helicopter T…

616
Suzuki Motor

616
Uchicago Argonne

616

What this shows Institut holds 617 patents at rank #738, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Institut

By rank, the assignees closest to #738 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Institut's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Institut, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Institut ranks #38 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (62 here).

Sony Mobile Communications Inc. 62 Colgate-Palmolive Company 62 Panduit Corp. 62 Allison Transmission, Inc. 62

Similar claim depth

Nearest assignees by average claims per patent (13.6 here).

E.I. DU Pont DE Nemours AND Company 13.6 avg Konica Minolta, Inc. 13.6 avg Bull SAS 13.6 avg Universite De Montpellier 13.6 avg

Institut's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

62 Top 3% higher than 97% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Institut National de la Sante et de la Recherche Medicale (INSERM) patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	57	9.2%
2016	52	8.4%
2017	60	9.7%
2018	52	8.4%
2019	53	8.6%
2020	77	12.5%
2021	49	7.9%
2022	62	10.0%
2023	69	11.2%
2024	43	7.0%
2025partial year	43	7.0%

Which technologies does Institut National de la Sante et de la Recherche Medicale (INSERM) patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 361

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 341

C07K - Peptides 183

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 182

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 143

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 75

A61B - DIAGNOSIS; SURGERY; Identification 53

C07D - Heterocyclic Compounds 48

Y02A - Technologies FOR Adaptation TO Climate Change 41

C12Y - Enzymes 32

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 31

G06T - Image Data Processing OR Generation, IN General 20

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 15

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 15

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 14

Top 15 of 89 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Institut National de la Sante et de la Recherche Medicale (INSERM)'s patent record in context - here's where to go next.

Institut National de la Sante et de la Recherche Medicale (INSERM)'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 58.5% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #738 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Institut National de la Sante et de la Recherche Medicale (INSERM) against Baxter International Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 61.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.